OC-11 Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohortG Canavesi, Stefano Rusconi, Teresa Bini et al.|Unknown|2024Cited by 0
SC28 Adverse event development in people with HIV on long-acting Cabotegravir + rilpivirine: timing and clinical insightsGaia Cologgi, Antonio Di Biagio, L Taramasso et al.|Unknown|2025Cited by 0